Fluoride: A good choice in osteoporosis;Fluoride: Een goede keus bij osteoporose

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 34, 1998, Pages 1915-1919

  Duursma, S A ^a  

^a Afdeling Geriatrie   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; FLUORIDE;

AGED; BONE DENSITY; DRUG COMBINATION; DRUG EFFECT; FEMALE; HUMAN; MALE; MIDDLE AGED; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; REVIEW;

AGED; BONE DENSITY; DIPHOSPHONATES; DRUG THERAPY, COMBINATION; FEMALE; FLUORIDES; HUMANS; MALE; MIDDLE AGED; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS;

EID: 0032558195     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Roholm, K. Fluoride intoxication. A clinical hygienic study with a review of the literature and some experimental investigations. Londen: Lewis, 1937.
2. Leone NC, Stevenson CA, Hilbish TF, Sosman MC. A roentgenologic study of a human population exposed to high-fluoride domestic water. A ten-year study. Am J Röntgenol 1955:74:874-85.
3. Rich C, Ensinck J. Effect of sodium fluoride on calcium metabolism in human beings. Nature i96i;i9i:i84-5.
4. Cass RM, Croft jr JD, Perkins P, Nye W, Waterhouse C, Terry R. New bone formation in osteoporosis following treatment with sodium fluoride. Arch Intern Med 19665118:111-6.
5. Jowsey J, Schenk RK, Reutter FW. Some results of the effect of fluoride on bone tissue in osteoporosis. J Clin Endocrinol Metab 1968; 28:869-74.
6. Merz WA, Schenk RK, Reutter FW. Paradoxical effects of vitamin D in fluoride-treated senile osteoporosis. Calcif Tissue Res 1970; Suppl:49-50.
7. Jowsey J, Riggs BL, Kelly PJ, Hoffmann DL. Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis. Am J Med 1972:53:43-9.
8. Riggs BL, Seeman E, Hodgson SF, Taves DR, O'Fallon WM. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med 1982:306:446-50.
9. Riggs BL, Hodgson SF, O'Fallon WM, Chao EYS, Wahner HW, Muhs JMM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990; 322:802-9.
10. Kleerêkoper M, Peterson EL, Nelson DA, Philips E, Schork MA, Tilley BC, et al. A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis. Osteoporos Int 1991; 1:15561.
11. Eanes ED, Reddi AH. The effect of fluoride on bone mineral apatite. Metab Bone Dis Relat Res 1979:2:3-10.
12. Grynpas MD. Fluoride effects on bone crystals. J Bone Miner Res 1990:5 Suppl 1:8169-75.
13. Bellows CG, Aubin JE, Heersche JNM. Differential effects of fluoride during initiation and progression of mineralization of osteoid nodules formed in vitro. J Bone Miner Res 1993:8:1357-63.
14. Grynpas MD, Cheng PT. Fluoride reduces the rate of dissolution of bone. Bone Miner 1988:5:1-9.
15. Turner CH, Boivin G, Meunier PJ. A mathematical model for fluoride uptake by the skeleton. Calcif Tissue Int 1993:52:130-8.
16. Boivin G, Meunier PJ. Effects of fluoride on bone mineral. Res Clin Forums 1993:15:13-9.
17. Einhorn TA, Wakley GK, Linkhart S, Rush EB, Maloney S, Faierman E, et al. Incorporation of sodium fluoride into cortical bone does not impair the mechanical properties of the appendicular skeleton in rats. Calcif Tissue Int 1992:51:127-31.
18. Parley JR, Tarbaux N, Hall S, Baylink DJ. Mitogenic action(s) of fluoride on osteoblast line cells: determinants of the response in vitro. J Bone Miner Res 1990:5 Suppl 1:8107-13.
19. Khokher MA, Dandona P. Fluoride stimulates (3H)thymidine incorporation and alkaline phosphatase production by human osteoblasts. Metabolism 1990:39:1118-21.
20. Marie PJ, De Vernejoul MC, Lomri A. Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro. J Bone Miner Res 1992:7:103-13.
21. Lau KHW, Parley JR, Freeman TK, Baylink DJ. A proposed mechanism of the mitogenic action of fluoride on bone cells: inhibition of the activity of an osteoblastic acid phosphatase. Metabolism 1989:38:858-68.
22. Bonjour JP, Caverzasio J, Rizzoli R. Effect of fluoride on bone cells. Res Clin Forums 1993:15:9-12.
23. Baylink DJ, Parley JR, Lau KHW, Wergedal J. Sodium fluoride does not increase human bone cell proliferation or protein synthesis in vitro [letterJ. Calcif Tissue Int 1992:50:96-7.
24. Chavassieux P, Boivin G, Serre CM, Meunier PJ. Fluoride increases rat osteoblast function and population after in vivo administration but not after in vitro exposure. Bone 1993:14:721-5.
25. Caverzasio J, Imai T, Ammann P, Burgener D, Bonjour JP. Aluminium potentiates the effect of fluoride on tyrosine phosphorylation and osteoblast replication in vitro and bone mass in vivo. J Bone Miner Res 1996:11:46-55.
26. Baylink DJ, Bernstein DS. The effects of fluoride therapy on metabolic bone disease. A histologie study. Clin Orthop 1967:55:51-85.
27. Lundy MW, Wergedal JE, Teubner E, Burnell J, Sherrard D, Baylink DJ. The effect of prolonged fluoride therapy for osteoporosis: bone composition and histology. Bone 1989:10:321-7.
28. Kesteren RG van, Duursma SA, Visser WJ, Sluys Veer J van der, Backer Dirks O. Fluoride in serum and bone during treatment of osteoporosis with sodium fluoride, calcium and vitamin D. Metab Bone Dis Relat Res 1982:4:31-7.
29. Lioté F, Bardin C, Liou A, Brouard A, Terrier JL, Kuntz D. Bioavailability of fluoride in postmenopausal women: comparative study between sodium fluoride and disodium monofluorophosphate-calcium carbonate. Calcif Tissue Int 1992:50:209-13.
30. Asten P van, Duursma SA, Glerum JH, Ververs FFT, Rijn HJM van, Dijk A van. Absolute bioavailability of fluoride from disodium fluorophosphate and enteric-coated sodium fluoride tablets. Eur J Clin Pharmacol 1996:50:321-6.
31. Ekstrand J, Ehrnebo M. Influence of milk products on fluoride bioavailability in man. Eur J Clin Pharmacol 1979:16:211-5.
32. Trautner K. Influence of food on relative bioavailability of fluoride in man from Na2FPO3-containing tablets for the treatment of osteoporosis. Int J Clin Pharmacol Ther Toxicol 1989:27:242-9.
33. Parley JR, Tarbaux NM, Lau KHW, Baylink DJ. Monofluorophosphate is hydrolyzed by alkaline phosphatase and mimics the actions of NaF on skeletal tissues, in vitro. Calcif Tissue Int 1987:40:3542.
34. Ericsson Y, Patterson C. Studies on the hydrolysis and absorption of monofluorophosphate ions. Pharmacol Ther Dent 1980:5:47-54.
35. Setnikar I, Arigoni R. Chemical stability and mode of gastrointestinal absorption of sodium monofluorophosphate. Arzneimittelforschung 1988:38:45-9.
36. Spencer H, Kramer L, Norris C, Wiatrowski E. Effect of aluminium hydroxide on fluoride metabolism. Clin Pharmacol Ther 1980:28: 529-35-
37. Arnold P, Wermeille M, Chapuy MC, Biollaz J, Grandjean EM, Schelling JL, et al. Influence of food and antacid administration on fluoride bioavailability from enteric-coated sodium fluoride tablets. Bone 1989:10:401-7.
38. Whitford GM. The physiological and toxicological characteristics of fluoride. J Dent Res i99o;69(spec iss):539-49.
39. Schiffl H, Hofmann U, Huggler M, Binswanger U. Renal fluoride excretion: experimental evaluation of the role of extracellular volume status during intact and impaired kidney function. Nephron 1981:29:245-9.
40. Whitford GM, Pashley DH. The effect of body fluid pH on fluoride distribution, toxicity and renal clearance. In: Johansen E, Taves DR, Oison TO, editors. Continuing evaluation of the use of fluorides. AAS Selected symposium series no n. Boulder, Colo.: Westview, 1979:187-221.
41. Delmas PD, Dupuis J, Duboeuf F, Chapuy MC, Meunier PJ. Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride. J Bone Miner Res 1990:5 Suppl 1:8143-7.
42. Hasling C, Nielsen HE, Meisen F, Mosekilde L. Safety of osteoporosis treatment with sodium fluoride, calcium phosphate and vitamin D. Miner Electrolyte Metab 1987:13:96-103.
43. Asten P van, Darroudy F, Natarjan AT, Terpstra IJ, Duursma SA. Investigation of cytogenicity of patients after longterm fluoride therapy in osteoporosis. PWS Pharmacy World Science [ter perseJ.
44. Pak CYC. Fluoride and osteoporosis. Proc Soc Exp Biol Med 1989:191:278-86.
45. O'Duffy JD, Wahner H, O'Fallon WM, Johnson KA, Muhs JM, Beabout JW, et al. Mechanism of acute lower extremity pain syndrome in fluoride-treated osteoporotic patients. Am J Med 1986:80: 561-6.
46. Duursma SA, Raymakers JA, Fakkeldij TMV, Asten P van. Pharmacokinetics of monofluorophosphate. Res Clin Forums 1993:15: 21-31.
47. Bongers V, Raymakers JA, Rijk PP van, Duursma SA. Effects of combination therapy with bisphosphonate and sodiummonofluorophosphate on bone mass in osteoporosis. Osteoporosis Int 1996; 6(Suppl):244.
48. Duursma SA, Glerum J, Dijk A van, Bosch R, Kerkhoff H, Putten J van, et al. Responders and non-responders after fluoride therapy in osteoporosis. Bone 1987:8:131-6.
49. Duursma SA, Raymakers JA, Raadt ME de, Karsdorp NJHG, Dijk A van, Glerum J. Urinary fluoride excretion in responders and nonresponders after fluoride therapy in osteoporosis. J Bone Miner Res 1990:5 Suppl 1:843-7.
50. Hodsman AB, Drost DJ. The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride. J Clin Endocrinol Metab 1989:69:932-8.
51. Kraenzlin ME, Kraenzlin C, Parley SMG, Fitzdmmons RJ, Baylink DJ. Fluoride pharmacokinetics in good and poor responders to fluoride therapy. J Bone Miner Res 1990:5 Suppl 1:849-52.
52. Parley SM, Libanati CR, Odvina CV, Smith L, Eliel L, Wakley GK, et al. Efficacy of long-term fluoride and calcium therapy in correcting the deficit of spinal bone density in osteoporosis. J Clin Epidemiol 1989:42:1067-74.
53. Mamelle N, Meunier PJ, Dusan R, Guillaume M, Martin JL, Gaucher A, et al. Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet 1988-4:361-5.
54. Riggs BL, O'Fallon WM, Lane A, Hodgson SF, Wahner HW, Muhs J, et al. Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis. J Bone Miner Res 1994:9:265-75.
55. Sebert JL, Richard P, Mennecier I, Bisset JP, Loeb G. Monofluorophosphate increases lumbar bone density in osteopenic patients: a double-masked randomized study. Osteoporos Int 1995:5: 108-14.
56. Gambacciani M, Spinetti A, Taponeco F, Piaggesi L, Cappagli B, Ciaponi M, et al. Treatment of postmenopausal vertebral osteopenia with monofluorophosphate: a long-term calcium-controlled study. Osteoporos Int 1995:5:467-71.
57. Pak CYC, Sakhaee K, Adams-Huet B, Piziak V, Peterson RD, Poindexter JR. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial. Ann Intern Med 1995:123:401-8.
58. Guaydier-Souquières G, Kotzki PO, Sabatier JP, Basse-Cathalinat B, Loeb G. In corticosteroid-treated respiratory diseases, monofluorophosphate increases lumbar bone mineral density: a doublemasked randomized study. Osteoporos Int i996;6:i7l-7.
59. Rizzoli R, Chevalley T, Slosman DO, Bonjour JP. Sodium monofluorophosphate increases vertebral bone mineral density in patients with corticosteroids-induced osteoporosis. Osteoporos Int I995;5: 39-46.
60. 2O.
61. Libanati CR, Parley SM, Resch H, Baylink DJ. Fluoride therapy for osteoporosis. Res Clin Forums 1993:15:53-64.